Bacteriophages are viruses that solely ... fibrosis who experience chronic P aeruginosa infections. Vertex's gene-editing therapy for sickle cell disease, Casgevy, has been given the nod for ...

The growing demand for personalized medicine and advancements in phage therapy research are further driving industry growth. Scientists and healthcare professionals are increasingly exploring ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

The one-off gene therapy, known as exagamglogene autotemcel (or ‘exa-cel’), has been approved for use on the NHS in England from today (Friday 31 January) by the National Institute for Health and Care ...

Asiawu Imam says the therapy will make a huge difference A gene-editing therapy for sickle cell disease, with a price tag of £1.65m, is to be offered to patients on the NHS in England.

An in vivo base editing approach targeting the PRNP gene led to a 52% increase in the lifespan of mouse models inoculated with the most common sporadic and genetic types of human pathogenic prion ...

LONDON, Jan 31 (Reuters) - Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the National Institute for Health and Care ...

Gene regulation refers to the mechanisms that act to induce or repress the expression of a gene. These include structural and chemical changes to the genetic material, binding of proteins to ...

Complementary discoveries have the potential to enhance treatment options for antibiotic-resistant infections. Researchers at ...

At some point, we all struggle to adjust to change and fail to respond to life’s challenges with our best effort. It’s normal to feel stuck. We at Remarkable Services (RS) believe people ...

Jan. 30, 2025 — A research group has developed new advanced light-controlled tools that enable precise control of proteins in real time in living cells. This groundbreaking research opens doors ...